Skip to Main Content

VA Neurosurgery

VA Logo

Our department has a proud tradition of providing excellent neurosurgical care for the men and women Veterans who have served our country in the armed forces. Yale neurosurgeons and neurosurgery residents staff the outpatient clinics, inpatient and emergency room consults, and perform spine, peripheral nerve, and cranial procedures on site at the West Haven campus of the VA Connecticut Healthcare System, located 3 miles from Yale New Haven Hospital. Neurosurgery residents have the opportunity to care for and learn from veterans at all stages of their neurosurgical management, from diagnosis and surgical planning in the clinic or emergency room, to active participation in the operating room and post-operative care, including long term follow up in clinic. Nationwide VA databases contain over 20 years of electronic health record data, providing a rich resource for epidemiological and patient oriented research projects by medical students, residents, and faculty.

  • Joseph King

    Associate Professor of Neurosurgery; Associate Program Director, Neurosurgery Residency, Neurosurgery; Chief, Neurosurgery, VA Connecticut Healthcare System; Director, Neurosurgical Outcomes Research

    Dr. King is Associate Professor of Neurosurgery; Associate Program Director, Neurosurgery Residency; Director of Neurosurgical Outcomes Research; and Chief of Neurosurgery at the VA Connecticut Healthcare System. During his neurosurgery residency at the Hospital of the University of Pennsylvania, Dr. King earned a Masters in Clinical Epidemiology and Biostatistics. Dr. King is certified by the American Board of Neurological Surgery, and has a general neurosurgical practice at the VA with a focus on spine disease.

    Dr. King’s research interests include using large databases to examine health care systems issues, the measurement of patient-oriented outcomes and quality of life in patients with neurologic disease, incorporating patient preferences into neurosurgical decision making, cost-effectiveness analyses of neurosurgical interventions, and COVID-19 in Veterans. Dr. King has obtained grant support from the National Institute of Neurologic Disorders and Stroke, the National Cancer Institute, the Veterans Health Administration, and the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves.

    Dr. King was awarded a Lusted Prize at the 1993 Society for Medical Decision Making annual meeting, Blue and Red ribbon poster prizes at the Congress of Neurological Surgeons 2001 annual meeting, and the 2003 Sonntag Award by the American Association of Neurological Surgeons/ Congress of Neurosurgeons Joint Section on Disorders of the Spine and Peripheral Nerves. Dr. King has authored or coauthored 60 peer-reviewed publications, 6 book chapters, and 66 published abstracts.

  • Kristopher Kahle

    Assistant Professor of Neurosurgery and of Cellular and Molecular Physiology; Pediatrics, and Cellular and Molecular Physiology; Director, Neonatal and Congenital Anomaly Neurosurgery

    Kristopher T. Kahle, M.D., Ph.D., is an Assistant Professor of Neurosurgery and Pediatrics and Cellular and Molecular Physiology at Yale School of Medicine, and Director of Neonatal and Congenital Anomaly Neurosurgery in the Division of Pediatric Neurosurgery. He completed his MD and PhD degrees at the Yale School of Medicine under the mentorship of Richard Lifton, and neurosurgical residency at the Massachusetts General Hospital. After residency, Dr. Kahle completed his pediatric neurosurgery fellowship at Boston Children’s Hospital and was Instructor at Harvard Medical School. Dr. Kahle completed a postdoctoral research fellowship with Stephen Elledge and David Clapham at Harvard University. Dr. Kahle’s primary clinical practice includes disorders of neurodevelopment (hydrocephalus, arachnoid cysts, congenital vascular malformations, chiari malformations, spina bifida, and tethered spinal cord) and tumors of the pediatric brain and spinal cord. Dr. Kahle trained in neuroendoscopy, including third ventriculostomy and choroid plexus coagulation, with Dr. Benjamin Warf at Harvard. Dr. Kahle is an attending physician at Yale New Haven Hospital and the Yale New Haven Children’s Hospital. Dr. Kahle’s research is devoted to identifying the genes and pathways that regulate ion and water homeostasis in the developing nervous system, and how genetically-encoded or maladaptive changes in these processes contribute to the cellular, circuit, and behavioral abnormalities in neurodevelopmental disorders and in the traumatized brain. He also uses molecular genetic tools such as whole exome and genome sequencing to discover the molecular determinants of neurodevelopmental diseases, such as congenital hydrocephalus. The goal of his work is to translate advances in basic science into novel therapeutic strategies for pediatric neurosurgical diseases.